| LOGO OF SHIRINBANU GLOBAL PEACE OF NATIONS TRADING LTD.
2303632 03 Jan 2024 | on 03 Jan 2024 | Class 029 Class 029 Meats and Processed Food Products Butter; canned chickpeas; canned chili; canned cooked meats; canned cooked vegetables; canned fish; canned fruits and vegetables; canned green beans; canned meat spreads; canned olives; canned pasta foods; canned seafood; canned soups; canned tomatoes; cheese; compotes; eggs; fish; jellies and jams; meat; meat extracts; milk; poultry and game; vegetable oils and fats for food Class 030 Class 030 Staple Food Products Bread and pastry; candy; cereal flour; chocolate; dried herbs for food purposes; flour; fruit paste for flavouring of food; honey and treacle; ice cream; ice-cream-based snack foods; preserved garden herbs; salt and seasonings; sauce mixes; sauces for meat; spices; sugar; sugar confectionary; vinegar; yeast Class 031 Natural Agricultural Products Fresh herbs; horticultural seeds; malt for brewing and distilling; natural plants and flowers; plant seeds; raw grains; raw nuts; seedlings; seeds for agricultural purposes; seeds for fruit and vegetables
Class 032 Light Beverage Products Fruit juices; fruit-based beverages; mineral and aerated waters; non-alcoholic carbonated drinks; syrups for making beverages
Class 033 Wines and Spirits Products Alcoholic cocktails; alcoholic coolers; alcoholic punches; alcoholic seltzer; aperitifs with a distilled alcoholic liquor base; arak; brandy; champagne; cognac; gin; gin cocktails; hard seltzer; liqueur; rum; tequila; vodka; vodka cocktails; whisky; wine
Class 035 Advertising, Business & Retail Services Operation of a retail and online store selling food products; wholesale distributorship of food products
Class 043 Restaurant and Hotel Services Cocktail lounge services; restaurant services | | | LOGINU BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1342987 11 Apr 2007 | on 04 May 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical antibodies for the treatment of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome;diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents. | | | LOJINU BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1342982 11 Apr 2007 | on 04 May 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical antibodies for the treatment of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome;diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents. | | 
